CorMedix CRMD Stock
CorMedix Price Chart
CorMedix CRMD Financial and Trading Overview
| CorMedix stock price | 9.1 USD |
| Previous Close | 5.45 USD |
| Open | 5.5 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 5 - 5.58 USD |
| 52 Week Range | 2.71 - 8.03 USD |
| Volume | 916.28K USD |
| Avg. Volume | 343.12K USD |
| Market Cap | 234.6M USD |
| Beta (5Y Monthly) | 2.160915 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.67 USD |
CRMD Valuation Measures
| Enterprise Value | 179.66M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.744445 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4060.8467 |
| Price/Book (mrq) | 4.2656765 |
| Enterprise Value/Revenue | 3109.805 |
| Enterprise Value/EBITDA | -5.203 |
Trading Information
CorMedix Stock Price History
| Beta (5Y Monthly) | 2.160915 |
| 52-Week Change | 83.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.03 USD |
| 52 Week Low | 2.71 USD |
| 50-Day Moving Average | 4.96 USD |
| 200-Day Moving Average | 4.04 USD |
CRMD Share Statistics
| Avg. Volume (3 month) | 343.12K USD |
| Avg. Daily Volume (10-Days) | 443.31K USD |
| Shares Outstanding | 45.38M |
| Float | 44.74M |
| Short Ratio | 7.46 |
| % Held by Insiders | 1.08% |
| % Held by Institutions | 25.63% |
| Shares Short | 2.62M |
| Short % of Float | 5.80% |
| Short % of Shares Outstanding | 5.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -59905.80% |
| Gross Margin | 96.17% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.84% |
| Return on Equity (ttm) | -58.41% |
Income Statement
| Revenue (ttm) | 57.77K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 61.67K USD |
| EBITDA | -34527556 USD |
| Net Income Avi to Common (ttm) | -33234736 USD |
| Diluted EPS (ttm) | -0.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 55.6M USD |
| Total Cash Per Share (mrq) | 1.23 USD |
| Total Debt (mrq) | 770.01K USD |
| Total Debt/Equity (mrq) | 1.43 USD |
| Current Ratio (mrq) | 12.147 |
| Book Value Per Share (mrq) | 1.212 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28006276 USD |
| Levered Free Cash Flow (ttm) | -16648976 USD |
Profile of CorMedix
| Country | United States |
| State | NJ |
| City | Berkeley Heights |
| Address | 300 Connell Drive |
| ZIP | 07922 |
| Phone | 908 517 9500 |
| Website | https://www.cormedix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 40 |
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Q&A For CorMedix Stock
What is a current CRMD stock price?
CorMedix CRMD stock price today per share is 9.1 USD.
How to purchase CorMedix stock?
You can buy CRMD shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CorMedix?
The stock symbol or ticker of CorMedix is CRMD.
Which industry does the CorMedix company belong to?
The CorMedix industry is Biotechnology.
How many shares does CorMedix have in circulation?
The max supply of CorMedix shares is 65.54M.
What is CorMedix Price to Earnings Ratio (PE Ratio)?
CorMedix PE Ratio is now.
What was CorMedix earnings per share over the trailing 12 months (TTM)?
CorMedix EPS is -0.3 USD over the trailing 12 months.
Which sector does the CorMedix company belong to?
The CorMedix sector is Healthcare.
CorMedix CRMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Global Market Composite NQGM | 1839.71 USD — |
-3.16
|
— — | 1825.54 USD — | 1881.06 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}